Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays a 403 Forbidden error page, replacing the expected content with an access-denied message and a Home link.SummaryDifference17%

- Check24 days agoChange DetectedUpdated page revision from v3.6.6 to v3.7.0, signaling a new version of the ClinicalTrials.gov study page. This metadata update does not affect the study details or content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a minor platform release.SummaryDifference0.0%

- Check45 days agoChange DetectedThe study record now includes a funding source entry for 2018 (U.S. NIH Grant/Contract), clarifying NIH support for the trial.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new build of the page. This reflects a minor update to the page content or its presentation.SummaryDifference0.0%

Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.